🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Qi Cao

China General Nuclear Power Corporation (China)

ORCID: 0000-0001-6901-8928

Also affiliated with International Isotopes (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cis-4-[18F]fluoro-L-proline PET/CT molecular imaging quantifying liver collagenogenesis: No existing fibrotic deposition in experimental advanced-stage alcoholic liver fibrosis”.

Cis-4-[18F]fluoro-L-proline PET/CT molecular imaging quantifying liver collagenogenesis: No existing fibrotic deposition in experimental advanced-stage alcoholic liver fibrosis

Frontiers in Nuclear Medicine(2022)10.3389/fnume.2022.952943

N/A

0DataRank · unranked

1 citations

Hongxia Chen, Liya Pi, Youssef Ali, Qi Cao, Na Duan

Lung Fibrosis Conventional and Molecular Imaging Diagnosis Update

American Journal of Biomedical Science & Research(2022)10.34297/ajbsr.2022.16.002217

N/A

0DataRank · unranked

0 citations

Qi Cao

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes

Biomedicines(2024)10.3390/biomedicines12010196

N/A

0DataRank · unranked

3 citations

Pablo Saenz-Lopez Larrocha, Payal Dhar, Sizhe Liu, Milan M. Medd, Shengxian Jia +3 more